Therefore, we developed the RMW_Score scoring model (consisting of one distinct RNA methylation modification pattern (RBM15B) and two related genes (TCP1 and ANKRD36)) to quantify RNA methylation modification patterns in individual tumors, predicting the prognosis of BC patients and facilitating effective therapeutic strategies. Here, RBM15B is linked to breast cancer.